Immunonutrition suppresses acute inflammatory responses through modulation of resolvin E1 in patients undergoing major hepatobiliary resection

Surgery (United States)

Volumn 160, Issue 1, 2016, Pages 228-236

  Uno, Hidehiko ^a   Furukawa, Katsunori ^a   Suzuki, Daisuke ^a   Shimizu, Hiroaki ^a   Ohtsuka, Masayuki ^a   Kato, Atsushi ^a   Yoshitomi, Hideyuki ^a   Miyazaki, Masaru ^a  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; ICOSAPENTAENOIC ACID; INTERLEUKIN 6; LIPID BINDING PROTEIN; NUCLEOTIDE; RESOLVIN E1; UNCLASSIFIED DRUG; 5S,12R,18R-TRIHYDROXY-6Z,8E,10E,14Z,16E-EICOSAPENTAENOIC ACID;

ABDOMINAL ABSCESS; ABDOMINAL SURGERY; AGED; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BILE DUCT CARCINOMA; BILE LEAKAGE; CANCER SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FATTY ACID BLOOD LEVEL; FEMALE; GALLBLADDER CARCINOMA; HEMIHEPATECTOMY; HUMAN; IMMUNONUTRITION; IMMUNOTHERAPY; INFLAMMATION; LIVER FAILURE; MALE; NUTRITION; PNEUMONIA; PORTAL VEIN THROMBOSIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SEPSIS; SURGICAL INFECTION; ANALOGS AND DERIVATIVES; BILE DUCT NEOPLASMS; CARCINOMA; DIETARY SUPPLEMENT; ENTERIC FEEDING; LIVER RESECTION; MIDDLE AGED; PHYSIOLOGY; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDY;

AGED; ARGININE; BILE DUCT NEOPLASMS; CARCINOMA; DIETARY SUPPLEMENTS; EICOSAPENTAENOIC ACID; ENTERAL NUTRITION; FEMALE; HEPATECTOMY; HUMANS; MALE; MIDDLE AGED; NUCLEOTIDES; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES;

EID: 84960982068     PISSN: 00396060     EISSN: 15327361     Source Type: Journal    
DOI: 10.1016/j.surg.2016.01.019     Document Type: Article

References (34)

1. 1 Gianotti, L., Braga, M., Nespoli, L., Radaelli, G., Beneduce, A., Di Carlo, V., A randomized controlled trial of preoperative oral supplementation with a specialized diet in patients with gastrointestinal cancer. Gastroenterology 122 (2002), 1763–1770.
2. 2 Senkal, M., Zumtobel, V., Bauer, K.H., Marpe, B., Wolfram, G., Frei, A., et al. Outcome and cost-effectiveness of perioperative enteral immunonutrition in patients undergoing elective upper gastrointestinal tract surgery: a prospective randomized study. Arch Surg 134 (1999), 1309–1316.
3. 3 Suzuki, D., Furukawa, K., Kimura, F., Shimizu, H., Yoshidome, H., Ohtsuka, M., et al. Effects of perioperative immunonutrition on cell-mediated immunity, T helper type 1 (Th1)/Th2 differentiation, and Th17 response after pancreaticoduodenectomy. Surgery 148 (2010), 573–581.
4. 2 production and T-cell differentiation in patients undergoing pancreaticoduodenectomy. Surgery 155 (2014), 124–133.
5. 5 Hayashi, N., Tashiro, T., Yamamori, H., Takagi, K., Morishima, Y., Otsubo, Y., et al. Effect of intravenous omega-6 and omega-3 fat emulsions on nitrogen retention and protein kinetics in burned rats. Nutrition 15 (1999), 135–139.
6. 6 Furukawa, K., Tashiro, T., Yamamori, H., Takagi, K., Morishima, Y., Sugiura, T., et al. Effects of soybean oil emulsion and eicosapentaenoic acid on stress response and immune function after a severely stressful operation. Ann Surg 229 (1999), 255–261.
7. 7 Serhan, C.N., Hong, S., Gronert, K., Colgan, S.P., Devchand, P.R., Mirick, G., et al. Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J Exp Med 196 (2002), 1025–1037.
8. 8 Serhan, C.N., Chiang, N., Van Dyke, T.E., Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol 8 (2008), 349–361.
9. 9 Sawada, Y., Honda, T., Hanakawa, S., Nakamizo, S., Murata, T., Ueharaguchi-Tanada, Y., et al. Resolvin E1 inhibits dendritic cell migration in the skin and attenuates contact hypersensitivity responses. J Exp Med 212 (2015), 1921–1930.
10. 10 Campbell, E.L., Louis, N.A., Tomassetti, S.E., Canny, G.O., Arita, M., Serhan, C.N., et al. Resolvin E1 promotes mucosal surface clearance of neutrophils: a new paradigm for inflammatory resolution. FASEB J 21 (2007), 3162–3170.
11. 11 Fredman, G., Serhan, C.N., Specialized proresolving mediator targets for RvE1 and RvD1 in peripheral blood and mechanisms of resolution. Biochem J 437 (2011), 185–197.
12. 12 Mangram, A.J., Horan, T.C., Pearson, M.L., Silver, L.C., Jarvis, W.R., Guideline for prevention of surgical site infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee. Am J Infect Control 27 (1999), 97–132.
13. 13 Garner, J.S., Jarvis, W.R., Emori, T.G., Horan, T.C., Hughes, J.M., CDC definitions for nosocomial infections. Am J Infect Control 1988 (1988), 128–140.
14. 14 Bone, R.C., Balk, R.A., Cerra, F.B., Dellinger, R.P., Fein, A.M., Knaus, W.A., et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101 (1992), 1644–1655.
15. 15 Levy, M.M., Fink, M.P., Marshall, J.C., Abraham, E., Angus, D., Cook, D., et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 31 (2003), 1250–1256.
16. 16 Rahbari, N.N., Garden, O.J., Padbury, R., Brooke-Smith, M., Crawford, M., Adam, R., et al. Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery 149 (2011), 713–724.
17. 17 Koch, M., Garden, O.J., Padbury, R., Rahbari, N.N., Adam, R., Capussotti, L., et al. Bile leakage after hepatobiliary and pancreatic surgery: a definition and grading of severity by the International Study Group of Liver Surgery. Surgery 149 (2011), 680–688.
18. 18 Dindo, D., Demartines, N., Clavien, P.A., Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240 (2004), 205–213.
19. 19 Nagino, M., Kamiya, J., Uesaka, K., Sano, T., Yamamoto, H., Hayakawa, N., et al. Complications of hepatectomy for hilar cholangiocarcinoma. World J Surg 25 (2001), 1277–1283.
20. 20 Esaki, M., Shimada, K., Nara, S., Kishi, Y., Sakamoto, Y., Kosuge, T., et al. Left hepatic trisectionectomy for advanced perihilar cholangiocarcinoma. Br J Surg 100 (2013), 801–807.
21. 21 Neuhaus, P., Jonas, S., Bechstein, W.O., Lohmann, R., Radke, C., Kling, N., et al. Extended resections for hilar cholangiocarcinoma. Ann Surg 230 (1999), 808–818.
22. 22 Cerantola, Y., Hübner, M., Grass, F., Demartines, N., Schäfer, M., Immunonutrition in gastrointestinal surgery. Br J Surg 98 (2011), 37–48.
23. 23 Braga, M., Gianotti, L., Radaelli, G., Vignali, A., Mari, G., Gentilini, O., et al. Perioperative immunonutrition in patients undergoing cancer surgery: results of a randomized double-blind phase 3 trial. Arch Surg 134 (1999), 428–433.
24. 24 Braga, M., Gianotti, L., Vignali, A., Carlo, V.D., Preoperative oral arginine and n-3 fatty acid supplementation improves the immunometabolic host response and outcome after colorectal resection for cancer. Surgery 132 (2002), 805–814.
25. 25 Schwab, J.M., Chiang, N., Arita, M., Serhan, C.N., Resolvin E1 and protectin D1 activate inflammation-resolution programmes. Nature 447 (2007), 869–874.
26. 26 Serhan, C.N., Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways. Annu Rev Immunol 25 (2007), 1011–1037.
27. 27 Serhan, C.N., Clish, C.B., Brannon, J., Colgan, S.P., Chiang, N., Gronert, K., Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing. J Exp Med 192 (2000), 1197–1204.
28. 28 Arita, M., Bianchini, F., Aliberti, J., Sher, A., Chiang, N., Hong, S., et al. Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1. J Exp Med 201 (2005), 713–722.
29. 29 Haworth, O., Cernadas, M., Yang, R., Serhan, C.N., Levy, B.D., Resolvin E1 regulates interleukin 23, interferon-gamma and lipoxin A4 to promote the resolution of allergic airway inflammation. Nat Immunol 9 (2008), 873–879.
30. 30 Hudert, C.A., Weylandt, K.H., Lu, Y., Wang, J., Hong, S., Dignass, A., et al. Transgenic mice rich in endogenous omega-3 fatty acids are protected from colitis. Proc Natl Acad Sci U S A 103 (2006), 11276–11281.
31. 31 Bansal, V., Syres, K.M., Makarenkova, V., Brannon, R., Matta, B., Harbrecht, B.G., et al. Interactions between fatty acids and arginine metabolism: implications for the design of immune-enhancing diets. JPEN J Parenter Enteral Nutr 29 (2005), S75–S80.
32. 32 Sultan, J., Griffin, S.M., Di Franco, F., Kirby, J.A., Shenton, B.K., Seal, C.J., et al. Randomized clinical trial of omega-3 fatty acid-supplemented enteral nutrition versus standard enteral nutrition in patients undergoing oesophagogastric cancer surgery. Br J Surg 99 (2012), 346–355.
33. 33 van Bokhorst-De Van Der Schueren, M.A., Quak, J.J., von Blomberg-van der Flier, B.M., Kuik, D.J., Langendoen, S.I., Snow, G.B., et al. Effect of perioperative nutrition, with and without arginine supplementation, on nutritional status, immune function, postoperative morbidity, and survival in severely malnourished head and neck cancer patients. Am J Clin Nutr 73 (2001), 323–332.
34. 34 Hegazi, R.A., Hustead, D.S., Evans, D.C., Preoperative standard oral nutrition supplements vs immunonutrition: results of a systematic review and meta-analysis. J Am Coll Surg 219 (2014), 1078–1087.